Home
/
LISATA THERAPEUTICS, INC. (LSTA)
LISATA THERAPEUTICS, INC. (LSTA) Technical Analysis
Updated: 2026-05-01 03:18 UTC · Last close: 3.12 (-3.11%) · Support: 1.81 · Resistance: 3.38
LISATA THERAPEUTICS, INC. (LSTA) technical analysis page covering price structure, support and resistance, momentum conditions and a fundamentals snapshot from WOI Scanner.
⚠️ Risk Line
losing 1.81 would weaken the current structure.
Quick Read
From a roadmap perspective, the setup is boxed by support near 1.81 and resistance around 3.38.
🎯 Decision Map
From a roadmap perspective, the setup is boxed by support near 1.81 and resistance around 3.38. A move through resistance would be needed to materially improve the chart, while a break of support would keep the pressure side dominant. Pattern-based invalidation is near 5.19; losing that area would weaken the active formation considerably.
📊 Technical Summary
LISATA THERAPEUTICS, INC. (LSTA) finished the session at 3.12 (-3.11%). Price has slipped under the 50-day average but remains above the 200-day average, leaving the longer-term structure intact even as medium-term momentum softens. 20-day momentum is notably weak at -37.72%; price remains inside its roughly 52-week range (1.86–5.04); and ATR14 volatility is elevated at roughly 11.17% of price. RSI(14) sits near 28.3, which signals relatively weak momentum conditions. RSI has been drifting lower recently, suggesting that upside momentum may be cooling slightly. MACD is positioned under the signal line, suggesting momentum recovery has not fully developed yet. The MACD histogram remains negative, suggesting momentum is still on the softer side. Recent trading volume is running below its typical 20-day average, which suggests participation remains relatively muted. The chart is currently flagging Double bottom. The most important nearby levels are support at 1.81 and resistance at 3.38. Clearing resistance would improve continuation odds, while slipping below support would weaken the present setup. On the fundamentals side, the latest snapshot shows Net income: -4.25M · EPS (basic): -0.49. For a fuller technical read, the interactive view adds overlays, pattern context and broader chart structure.
💼 Fundamentals Snapshot
Source: sec
Company
LISATA THERAPEUTICS, INC.
Note: This is an algorithmic technical snapshot (not financial advice).